The final of the four Singapore papers in the May supplementary issue of Clinical Infectious Diseases, and by no means the least, focused on carbapenem-resistant Enterobacteriaceae (CRE) in inpatients from public hospitals in Singapore. The majority of the data are from a cohort study, aptly titled CaPES (Carbapenemase-Producing Enterobacteriaceae in Singapore), initiated in 2013 to […]
Broadly defined, healthcare-associated infections (HAIs, also termed “hospital-acquired infections” or “nosocomial infections”) are infections that occur during the process of care in a healthcare facility, most commonly a hospital. They are an important quality indicator for healthcare institutions – conceptually, one would not really wish to be treated at a hospital where one’s risk of acquiring an […]
Methicillin-resistant Staphylococcus aureus (MRSA) was first discovered on 2nd October 1960 by Prof Margaret Patricia Jevons at the Public Health Laboratory in Collindale, London, UK. Methicillin (or celbenin as it was also known as then) became available for prescription in 1959, and the conventional narrative has always been that MRSA arose as a consequence of […]
Like most other infectious disease physicians and microbiologists, I have been following the evolving global Mycobacterium chimaera outbreak with interest. I knew nothing about M. chimaera (or that it even existed) until last year. It is an interesting organism – a slow-growing non-tuberculous mycobacteria (NTM – a “catchall classification” that includes all mycobacteria other than those belonging to the Mycobacterium […]
Naturally, this is biased by what I know and has been reported. But here is what I feel are the significant events in 2016. Outbreaks These are the most easily recalled and form the biggest group of infectious disease events by far. The major outbreaks this year include: Rotavirus gastroenteritis at Pek Kio Market affecting […]
I used to think that trying to establish antibiotic stewardship in Singapore in an outpatient setting, just like in private hospitals, was a relatively futile exercise. Multiple factors (or so I thought) contribute to the failure of any serious effort that goes beyond public or physician education, including: Patients who insist on antibiotics (and who can easily obtain […]
An ongoing Facebook discussion on medical tourism set me thinking about its implications. There are many who argue that more should be done to encourage the growth of Singapore’s medical tourism industry, which reached its peak In 2012. Reasons include regional stature, development of more specialized medical skills (due to a larger pool of patients […]
I had the pleasure of attending the 5th ICICAS held at Mandarin Orchard in Singapore from 19th to 21st October. Held every two years – which means this conference has been running for 10 years already – the programme this year was both innovative and interesting, and featured excellent international (and local, of course) speakers. […]
It was both a surprise and an honour to be invited for the lecture organised by the Science and Innovation Team of the British High Commission. Prof Sally Davies has been UK’s chief medical officer (equivalent in rank to permanent secretary in the civil service) since 2010, the first woman to attain that position. The […]
Took a truncated hiatus from Zika to attend the 17th International Sympsium on Staphylococci and Staphylococcal Infections held at the Nine Tree Convention Centre in Seoul, Korea. It’s a rather quaint and unique conference, centered around one single bacterial genus (but it’s almost all about Staphylococcus aureus and MRSA), held every two years rotating between […]
MIPHIDIC 